Ragweed allergy vaccine success for Allergy Therapeutics
This article was originally published in Scrip
Executive Summary
Allergy Therapeutics' ragweed allergy vaccination, Pollinex Quattro Ragweed, has met its primary endpoint in a pivotal Phase III trial.